author-photo

Barbara Grün

University Hospital Heidelberg

3

Papers

60

Citations

Citation Trend

Filter By

Papers (2) Sort By

Journal Conference Others

Combined PD-1 inhibition (Pembrolizumab) and CCR5 inhibition (Maraviroc) for the treatment of refractory microsatellite stable (MSS) metastatic colorectal cancer (mCRC): First results of the PICCASSO phase I trial.

2020 Journal of Clinical Oncology
Show All
- Source
- Cite
- Save
Citations (6)
Inhibition of the active principle of the weak opioid tilidine by the triazole antifungal voriconazole

2009 British Journal of Clinical Pharmacology
Show All
- Source
- Cite
- Save
Citations (11)